GlaxoSmithKline announces FDA approval ...( cine in December or even later can be...),Health

cine in December, or even later, can be beneficial in most years. Flu season can begin as early as October and last as late as May. People who should receive the influenza vaccine include the very young, people 50 years of age or older, the chronically ill, women who will be pregnant during influenza season and all healthcare workers. In addition to the public health threat influenza poses, the disease has economic repercussions. An average of approximately 226,000 influenza-related excess hospitalizations occurred per year in the United States between 1979 and 2001. Influenza epidemics can have a significant impact on the U.S. economy, as influenza infection results in an average of 2.8 lost workdays per episode, or $398 in lost wages for the average worker. Recent estimates put the cost of influenza epidemics to the economy at $71 $167 billion per year.

About FLUARIX™
FLUARIX should not be administered to anyone with known systemic hypersensitivity reactions to eggs, egg products, egg or chicken proteins, or any component of FLUARIX, or to anyone who has had a life-threatening reaction to previous administration of any influenza vaccine. The most common adverse event in a clinical trial was pain at the injection site. Less common adverse events were muscle aches, fatigue, and headache. Most adverse events in clinical trials were mild and self-limiting. (See adverse reactions section of the Prescribing Information for FLUARIX for other potential adverse events.) As with any vaccine, vaccination with FLUARIX may not protect 100% of susceptible individuals.

'"/>

Contact: Michael Fleming
919-483 2839
Cohn & Wolfe
31-Aug-2005

Page: 1 2 3
Related medicine news :

1. GlaxoSmithKline honors cancer research pioneer Gianni Bonadonna with new ASCO Award and Fellowship
2. IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2006 Innovation in Oral Care Awards
3. GlaxoSmithKline funds $1.65 million effort for UNC-Duke public health care partnership
4. GlaxoSmithKlines Havrix now approved for use in children aged 12 months and older
5. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
6. AstraZeneca announces SYMBICORT is now available in the US
7. Weill Cornell Medical College announces gifts totaling $400M
8. GSK announces launch of largest ever Phase III trial in lung cancer treatment
9. Elsevier announces launch of Brain Stimulation
10. NSW Premier announces $15M for childrens cancer research
11. National Inventors Hall of Fame announces 2007 inductees